Immigrants? advocates decry Gardasil requirement Westside Gazette - Nov 5, 2008 CDC?s Advisory Committee on Immunization Practices recommends the HPV vaccine for girls ages 11-12 and catch-up shots for women up to age 26. ...
How Safe is Gardasil the HPV ?Hot Shot?? MedIndia, India - Nov 21, 2008 Such is the case with Gardasil, the vaccine against the most common sexually transmitted virus - the Human Papilloma Virus (HPV). ...
Finding the right mix for head and neck cancer treatment HemOncToday, NJ - Nov 10, 2008 The HPV vaccine (Gardasil, Merck) has been approved to prevent gynecologic cancers. Many of the oncologists contacted for this story hope that something ...
Health Highlights: Nov. 16, 2008 U.S. News & World Report, DC - Nov 16, 2008 Gardasil protects against the sexually transmitted human papillomavirus (HPV). The 30-month study of 4065 males, ages 16 to 26, found that those who ...
Awards handed out health teams This Is Lancashire, UK - Nov 22, 2008 Bury was an early adopter site of the HPV vaccine. Adult Services Award (the Colin Caffrey Award): Learning Disability Team. Centred around the use of ...
QIAGEN and Institute for Animal Health Enter Partnership in ... International Business Times, NY - Nov 5, 2008 This panel includes the onlyFDA-approved test for human papillomavirus (HPV), the primary causeof cervical cancer. QIAGEN employs more than 2800 people in ...QGEN
Health Highlights: Nov. 15, 2008 Forbes, NY - Nov 15, 2008 Gardasil protects against the sexually transmitted human papillomavirus (HPV). The 30-month study of 4065 males, ages 16 to 26, found that those who ...
Girl Dies After HPV Jab - CDC Blames Birth Control Pills Natural News.com, AZ - Aug 5, 2008 (NaturalNews) Some people may remember the article about young Brittany who became paralyzed shortly after receiving the HPV vaccine. ...
Nurses face 'impossible' HPV workload Healthcare Republic - Aug 4, 2008 Nurses in practices and schools face an 'impossible' workload after the DoH announced plans to vaccinate 300000 teenagers against HPV starting next month. ...
A survivor?s battle with cervical cancer Inquirer.net, Philippines - Aug 4, 2008 HPV, affecting both men and women, can be acquired only through skin contact. Men are generally spared from the deadly virus and only serve as carriers. ...
HPV Vaccine Acceptability in a Rural Southern Area - KI Fazekas, NT Brewer, JS Smith - Journal of Women's Health - liebertonline.com ...HPV and cervical cancer beliefs Perceived likelihood of HPV infection b 0.23** 0.18* 0.17* 0.06 Perceived severity of HPV infection b 0.31** 0.11 0.09 0.09 ...
[CITATION] Return to article HPV Anal - JNCI Cancer Spectrum - Oxford Univ Press
[CITATION] Allyl Alcohol (CAS RN 107-18-6) High Production Volume (HPV) Chemical Challenge Data Review and … HPVHPVC Challenge -
Cervical neoplasia and the persistence of HPV infection in HIV+ women L Ahdieh, A Munoz, D Vlahov, C Trimble, L Timpson, … - Program and Abstracts of the 6th Conference on Retroviruses … - gateway.nlm.nih.gov ... The rate of HPV clearance in HIV+ women with CD4 200 mm3 and HIV+ women with CD4 <
200 mm3 was only 0.29 (CI: 0.17, 0.48) and 0.10 (CI: 0.04, 0.28) the rate of ...
Source: Google Scholar
Advisory Panel Recommends HPV Vaccine
An advisory panel to the US Food and Drug Administration (FDA) is recommending the agency approve a vaccine against the virus that causes most cases of cervical cancer. The panel gave the thumbs up to Merck's Gardasil on Thursday, concluding it is both safe and effective.
The FDA is not required to follow the recommendations of its advisory panels, but often does so. A final decision on approval is expected by June 8. If the vaccine is approved, a separate federal agency will make recommendations, probably later in June, on who should get it.
"HPV vaccines have the potential to prevent thousands of deaths from cervical cancer in the United States and millions of deaths worldwide," said Debbie Saslow, PhD, director for breast and gynecological cancers at the American Cancer Society.
Gardasil is 1 of 2 vaccines being developed to protect against HPV, or human papilloma virus. It targets 2 strains of the virus, HPV 16 and HPV 18, which are responsible for about 70% of all cervical cancers. It also targets 2 other strains that cause about 90% of genital warts. It does not have an effect on other strains of HPV, some of which may also lead to cervical cancer.
GlaxoSmithKline is developing the other HPV vaccine, called Cervarix, which has not yet been sent to the FDA for approval.
HPV is a very common sexually transmitted virus. Most people who have ever had sex, both men and women, have been infected at some point in their lives. Most people never even know they've had HPV because the virus usually doesn't cause any symptoms and the body is able to fight it off easily.
Sometimes, though, the virus doesn't go away. If the virus lingers in a woman's cervix, it can cause changes that eventually lead to cervical cancer.
Huge Global Toll From Cervical Cancer
Pap tests can find these changes before they become cancer, and can find cervical cancers early, when they are easier to treat. In the United States, widespread use of Pap tests has dramatically cut the death rate from this disease over the last few decades.
Still, more than 9,700 US women are expected to develop cervical cancer in 2006 and about 3,700 women to die from it. Worldwide, the disease kills more than 288,000 women each year, according to the World Health Organization.
A successful vaccine could slash that figure by preventing many potentially dangerous HPV infections in the first place. It could also reduce health care costs by cutting down on the number of cancers and pre-cancerous conditions that require expensive treatment.
But Saslow emphasized that screening for cervical cancer with Pap tests would still be important, even if an HPV vaccine is ultimately approved. It will also be very important to make vaccinations available in underserved communities where rates of Pap testing are low.
